Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies - Jeffrey Schlom; Claudia Palena; Sofia R Gameiro; Lucas A Horn; Kristin C Hicks; Christine M Minnar; Paul L Chariou (Journal for ImmunoTherapy of Cancer, 2022)